凯普生物跌2.11%，成交额5474.54万元，主力资金净流出828.21万元

Core Viewpoint - The stock of Capbio has experienced fluctuations, with a recent decline of 2.11% and a total market value of 3.898 billion yuan, while the company has shown a year-to-date increase of 12.08% in stock price [1] Group 1: Financial Performance - For the period from January to September 2025, Capbio reported a revenue of 486 million yuan, reflecting a year-on-year decrease of 20.38%, while the net profit attributable to shareholders was -128 million yuan, indicating a year-on-year increase of 51.25% [2] - Since its A-share listing, Capbio has distributed a total of 485 million yuan in dividends, with 193 million yuan distributed over the past three years [3] Group 2: Shareholder and Market Activity - As of December 31, the number of shareholders for Capbio was 26,900, a decrease of 1.70% from the previous period, with an average of 23,573 circulating shares per shareholder, which is an increase of 1.73% [2] - The main capital flow indicates a net outflow of 8.2821 million yuan, with significant selling activity from large orders [1]